These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 32967429)

  • 21. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
    Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
    Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
    Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
    United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn's disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression.
    Gomes RG; Brito CAA; Martinelli VF; Santos RND; Gomes FODS; Peixoto CA; Crispim JO; Diniz GTN; Donadi EA; Lucena-Silva N
    Hum Immunol; 2018 Jun; 79(6):477-484. PubMed ID: 29588183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn's disease and control subjects with no inflammatory bowel disease.
    Merigo F; Brandolese A; Facchin S; Boschi F; Di Chio M; Savarino E; D'Incà R; Sturniolo GC; Sbarbati A
    Cell Tissue Res; 2021 Mar; 383(3):1103-1122. PubMed ID: 33159578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease.
    Arai F; Takahashi T; Furukawa K; Matsushima K; Asakura H
    Dig Dis Sci; 1998 Sep; 43(9):2071-9. PubMed ID: 9753275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
    Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
    Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of pathologic features associated with "ulcerative colitis-like" Crohn's disease.
    James SD; Wise PE; Zuluaga-Toro T; Schwartz DA; Washington MK; Shi C
    World J Gastroenterol; 2014 Sep; 20(36):13139-45. PubMed ID: 25278708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: a study in Crohn's disease.
    Prager M; Durmus T; Büttner J; Molnar T; de Jong DJ; Drenth JP; Baumgart DC; Sturm A; Farkas K; Witt H; Büning C
    Scand J Gastroenterol; 2014 Oct; 49(10):1191-200. PubMed ID: 25098938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier.
    Felwick RK; Dingley GJR; Martinez-Nunez R; Sanchez-Elsner T; Cummings JRF; Collins JE
    J Crohns Colitis; 2020 Mar; 14(3):381-392. PubMed ID: 31626694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
    Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
    MacDermott RP; Schreiber S; Nash GS; Koopman WJ
    Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and localization of pannexin-1 hemichannels in human colon in health and disease.
    Diezmos EF; Sandow SL; Markus I; Shevy Perera D; Lubowski DZ; King DW; Bertrand PP; Liu L
    Neurogastroenterol Motil; 2013 Jun; 25(6):e395-405. PubMed ID: 23594276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.
    Singer II; Kawka DW; Schloemann S; Tessner T; Riehl T; Stenson WF
    Gastroenterology; 1998 Aug; 115(2):297-306. PubMed ID: 9679035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
    Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
    J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.
    Sherman Horev H; Rabinowitz KM; Elad H; Barkan R; Ben-Shachar S; Pasmanik Chor M; Dotan I
    Inflamm Bowel Dis; 2018 Apr; 24(5):1045-1054. PubMed ID: 29688474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.